Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 35BAYER HLTHCARE
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2834
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2834
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2834
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2834
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2834
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2835
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2835
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2835
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2835
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2034-02-18
US Patent Number : 12503469
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204819
Patent Use Code : U-2835
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-02-18
